Cargando…
Loss of immune tolerance to IL-2 in type 1 diabetes
Type 1 diabetes (T1D) is characterized by a chronic, progressive autoimmune attack against pancreas-specific antigens, effecting the destruction of insulin-producing β-cells. Here we show interleukin-2 (IL-2) is a non-pancreatic autoimmune target in T1D. Anti-IL-2 autoantibodies, as well as T cells...
Autores principales: | Pérol, Louis, Lindner, John M., Caudana, Pamela, Nunez, Nicolas Gonzalo, Baeyens, Audrey, Valle, Andrea, Sedlik, Christine, Loirat, Delphine, Boyer, Olivier, Créange, Alain, Cohen, José Laurent, Rogner, Ute Christine, Yamanouchi, Jun, Marchant, Martine, Leber, Xavier Charles, Scharenberg, Meike, Gagnerault, Marie-Claude, Mallone, Roberto, Battaglia, Manuela, Santamaria, Pere, Hartemann, Agnès, Traggiai, Elisabetta, Piaggio, Eliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059699/ https://www.ncbi.nlm.nih.gov/pubmed/27708334 http://dx.doi.org/10.1038/ncomms13027 |
Ejemplares similares
-
Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
por: Baeyens, Audrey, et al.
Publicado: (2013) -
Lymph node invasion by tumor cells modifies the distribution of dendritic cell subsets and memory T cell profiles in human cancer patients
por: Núñez, Nicolás Gonzalo, et al.
Publicado: (2014) -
Role of Cytokines in Thymus- Versus Peripherally Derived-Regulatory T Cell Differentiation and Function
por: Goldstein, Jérémie David, et al.
Publicado: (2013) -
Effects of interleukin-2 in immunostimulation and immunosuppression
por: Pol, Jonathan G., et al.
Publicado: (2019) -
TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity
por: Roselli, Emiliano, et al.
Publicado: (2019)